ClearPoint Neuro (CLPT) Shares Outstanding (Weighted Average) (2017 - 2026)
ClearPoint Neuro's Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $28.3 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 4.76% to $28.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 million, a 4.76% increase, with the full-year FY2025 number at $28.3 million, up 4.76% from a year prior.
- Shares Outstanding (Weighted Average) hit $28.3 million in Q4 2025 for ClearPoint Neuro, roughly flat from $28.4 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for CLPT hit a ceiling of $28.4 million in Q3 2025 and a floor of $18.9 million in Q1 2021.
- Historically, Shares Outstanding (Weighted Average) has averaged $24.8 million across 5 years, with a median of $24.6 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): soared 38.82% in 2021 and later increased 0.54% in 2023.
- Tracing CLPT's Shares Outstanding (Weighted Average) over 5 years: stood at $20.7 million in 2021, then grew by 16.63% to $24.2 million in 2022, then increased by 1.75% to $24.6 million in 2023, then grew by 9.85% to $27.0 million in 2024, then increased by 4.76% to $28.3 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for CLPT at $28.3 million in Q4 2025, $28.4 million in Q3 2025, and $28.3 million in Q2 2025.